BUSINESS: Research + Stats New Survey from B+L and Glaucoma Research Foundation Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients By Staff Tuesday, January 11, 2022 1:11 PM In time for Glaucoma Awareness Month in January, Bausch + Lomb released new data from a survey of glaucoma patients to better understand the impact of hyperemia in their glaucoma treatment and lives. The survey, which was conducted in partnership with the Glaucoma Research Foundation, uncovered the emotional and social cost of hyperemia on glaucoma patients, the impact hyperemia has on treatment adherence and the need for conversations between patients and their eyecare professionals to find the right treatment option for them.“Bausch + Lomb is proud to collaborate with Glaucoma Research Foundation to raise awareness of hyperemia and how it may have an impact on the lives of patients with glaucoma,” said Joe Gordon, U.S. president, Bausch + Lomb. “The survey results demonstrated that the emotional cost of hyperemia is high, with 71 percent of participants feeling self-conscious and 55 percent feeling embarrassed about their red eyes. It is our hope that by raising awareness of this issue, we can help facilitate discussions among patients and their eye care professionals about their options and the importance of adhering to their treatment regimen.”The survey included 101 adults, 18 years and older in the United States, who have glaucoma and have experienced hyperemia as a result of their treatment. The survey found that few glaucoma patients know about hyperemia when starting treatment for glaucoma, with 61 percent reporting that they only became aware of the condition after experiencing it themselves.Additionally, nearly half (43 out of 101) of the respondents reported talking to their doctors about changing their glaucoma treatment as a result of hyperemia, and 12 out of 101 either skipped doses or stopped using their prescription eye drops. Approximately 66 out of 101 participants reported feeling more confident when their eyes were not red, and respondents also indicated that there was some social stigma associated with having red eyes. In fact, one in 10 patients stopped their treatment in certain social or professional circumstances and 41 out of 101 noted concerns about experiencing negative social interactions as a result.“These findings build upon earlier evidence that hyperemia presents a challenge to people with glaucoma and sheds light on how the condition may not only impact how they treat their glaucoma, but how they live their lives,” said Andrew Iwach, MD, board chair, Glaucoma Research Foundation, and executive director, Glaucoma Center of San Francisco. “The results reinforce the importance for eye care professionals to have an open dialogue with their patients about the available treatment options and any concerns that they may have. This can help patients to feel confident about managing their glaucoma and demonstrate the importance of taking control of their eye health by maintaining the appropriate treatment regimen.”For more information on glaucoma, visit the GRF website at https://www.glaucoma.org/ or the Bausch + Lomb website at https://www.bausch.com/your-eye-concerns/diseases-and-disorders/glaucoma. The full survey data can be found online here.